The effect of catheter displacement on acute and late toxicity in fractionated HDR monotherapy of prostate cancer

被引：0
|
作者：
Aluwini, S. [1 ]
Bhawanie, A. [1 ]
Baartman, L. [1 ]
Alemayehu, W. Ghidey [2 ]
Busser, W. [1 ]
Boormans, J. [3 ]
Kolkman-Deurloo, I. K. [1 ]
机构：
[1] Erasmus MC, Dept Radiat Oncol, Inst Canc, Rotterdam, Netherlands
[2] Erasmus MC, Clin Trials Ctr, Inst Canc, Rotterdam, Netherlands
[3] Erasmus MC, Inst Canc, Dept Urol, Rotterdam, Netherlands
来源：
RADIOTHERAPY AND ONCOLOGY | 2015年 / 115卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OC-0036
引用
收藏
页码：S17 / S18
页数：2
相关论文
共 50 条
  • [1] HDR BRACHYTHERAPY AS MONOTHERAPY FOR EARLY STAGE PROSTATE CANCER: ACUTE TOXICITY
    Aluwini, S.
    van Rooij, P.
    Kirkels, W.
    Bangma, C.
    Kolkman-Deurloo, I. K.
    RADIOTHERAPY AND ONCOLOGY, 2011, 99 : S283 - S284
  • [2] Fractionated high-dose-rate brachytherapy as monotherapy in prostate cancer: Does implant displacement and its correction influence acute and late toxicity?
    Aluwini, Shafak
    Busser, Wendy M. H.
    Baartman, Lizette E. A.
    Bhawanie, Anand
    Alemayehu, Wendimagegn G.
    Boormans, Joost L.
    Kolkman-Deurloo, Inger-Karine K.
    BRACHYTHERAPY, 2016, 15 (06) : 707 - 713
  • [3] HDR and LDR comparison as monotherapy in localized prostate cancer: PSA kinetic and late toxicity
    Reynaud, T.
    Hathout, L.
    Carignan, D.
    Barkati, M.
    Martin, A.
    Foster, W.
    Lacroix, F.
    Delouya, G.
    Taussky, D.
    Vigneault, E.
    RADIOTHERAPY AND ONCOLOGY, 2021, 158 : S120 - S120
  • [4] HDR monotherapy for prostate cancer: A simulation study to determine the effect of catheter displacement on target coverage and normal tissue irradiation
    Kolkman-Deurloo, Inger-Karine K.
    Roos, Martin A.
    Aluwini, Shafak
    RADIOTHERAPY AND ONCOLOGY, 2011, 98 (02) : 192 - 197
  • [5] Dosimetric quality and acute toxicity in HDR-brachytherapy as monotherapy in low risk prostate cancer
    Isaak, B
    Thalmann, G
    Vock, J
    Rentsch, CA
    Manser, P
    Mini, R
    Greiner, RH
    Kolotas, C
    Aebersold, D
    STRAHLENTHERAPIE UND ONKOLOGIE, 2005, 181 : 131 - 131
  • [6] HDR monotherapy for localised prostate cancer
    Hoskin, PJ
    Bownes, P
    Ostler, P
    Bryant, L
    RADIOTHERAPY AND ONCOLOGY, 2005, 75 : S6 - S6
  • [7] HDR brachytherapy Monotherapy for prostate cancer: a one-day schedule phase II trial acute toxicity
    Jolicoeur, M.
    Nguyen, T. V.
    Derashodian, T.
    Hill, E.
    Mondat, M.
    Nachabe, M.
    Antebi, E.
    Wakil, G.
    Heliou, R.
    RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S139 - S140
  • [8] HDR brachytherapy as monotherapy in the treatment of prostate cancer
    Komina, Oxana
    Seitz-Kaestner, Christine
    Pajer, Thomas
    Kohl, Bettina
    Hummel, Johann
    Knocke-Abulesz, Tomas-Hendrik
    Nechvile, Elisabeth
    RADIOTHERAPY AND ONCOLOGY, 2024, 194 : S402 - S403
  • [9] HDR monotherapy brachytherapy for localised prostate cancer
    Hoskin, P. J.
    Bownes, P.
    Bryant, L.
    Ostler, P.
    CLINICAL ONCOLOGY, 2007, 19 (03) : S7 - S7
  • [10] HDR Brachytherapy as Monotherapy for Prostate Cancer: Early Toxicity of a Randomized Phase II Trial
    Jolicoeur, M.
    Derashodian, T.
    Nguyen-Huynh, T.
    Hillmann, E. de Castro
    Berbiche, D.
    Truchon, D.
    Heliou, R.
    Mondat, M.
    RADIOTHERAPY AND ONCOLOGY, 2021, 158 : S90 - S91
12345